Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Eureka 93 Inc LXLLF

Eureka 93 Inc is a Canada based company involved in hemp cultivation and CBD extraction operations in North America. The product offerings of the company include Wholesale CBD Products, Full Plant Extract and Isolate Powder.

GREY:LXLLF - Post Discussion

Eureka 93 Inc > Nextleaf - Run up to Health Canada license
View:
Post by stealthct on Jul 31, 2019 9:20am

Nextleaf - Run up to Health Canada license

Nextleaf is on track to be issued a Health Canada license for extraction. Once that occurs, the share price will go over $1.00. Contracts will be disclosed after the license. 

Best time to get into OILS. Lots of PR happening and US investors are getting in. Instituations are buying up on dark pools as well.

https://smallcappower.com/analyst-articles/nextleaf-solutions-extraction-stock/

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities